Catalyst is a niche provider of clinical research
services through two established solutions.
Premier provider of multi-therapeutic
resourcing and CRO services helping to
drive healthcare innovations to patients in need.
A biotech-focused, niche oncology CRO
helping to bring next-generation therapies
to cancer patients in need.
Your success is based on finding real solutions and getting real results.
You deserve a partner who is fully invested in giving you their undivided attention.
Building a culture of customer through collaboration and doing what’s right.
Latest News
Clinical Monitoring Oversight Case Study
Situation A small US-based biotech client needed Clinical Monitoring Oversight on a Global CNS Program. A large CRO was responsible for the clinical management on the Program. Client felt that additional support of the monitoring team via Clinical Oversight would...
Catalyst Clinical Research Named to Inc. 5000 List of Fastest-Growing Private Companies for Fourth Consecutive Year
The company ranked in the top half of the Inc. 5000 list with approximately a 202% increase in revenue from the previous period and a 246% in employee headcount. Wilmington, N.C. Aug. 15, 2023 – Catalyst Clinical Research, a market-leading provider of clinical...
Catalyst Clinical Research Announces the Acquisition of Genpro Research
Wilmington, NC, July 20, 2023 – Catalyst Clinical Research (“Catalyst”), an industry-leading provider of specialized clinical development solutions, announced today it has acquired Genpro Research (“Genpro”), a Massachusetts-based global clinical research organization...
“What makes a difference in this industry is how organizations stand behind their work. Catalyst has been hugely successful because of their integrity and commitment to their customers. No matter how big or small the project, they are your partner and that is why I continue to work with them.”
Mid-size Biopharma
